AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2019
Feb 8, 2019
29828_dirs_2019-02-08_e1e64620-eb89-48d6-b919-c9c597273e2d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-02-06
Reporting Person: Pletcher Brett A (EVP, Gen Counsel & Corp Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-06 | Common Stock | A | 9386 | — | Acquired | 30092 | Direct |
| 2019-02-06 | Common Stock | A | 6463 | — | Acquired | 36555 | Direct |
| 2019-02-06 | Common Stock | F | 3871 | $68.75 | Disposed | 32684 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-06 | Non-qualified Stock Option (Right to Buy) | $68.75 | A | 50480 | Acquired | 2029-02-06 | Common Stock (50480) | Direct |
| 2019-02-06 | Restricted Stock Unit | $ | A | 10910 | Acquired | Common Stock (10910) | Direct |
Footnotes
F1: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F3: The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F4: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2016, and February 16, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.
F5: Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.